Butterfly Network jumps on FDA clearance for AI-enabled lung tool
** Shares of digital health co Butterfly Network Inc
BFLY.N rise 24.06% to $2.28 after the bell
** Co says it has received U.S. FDA's 510(k) clearance for
AI-enabled lung tool
** The company expects the AI-enabled Auto B-line Counter to
launch early summer in the U.S.
** Auto B-line Counter uses deep-learning technology with
the aim of empowering providers to assess abnormal lung
conditions - BFLY
** Stock down ~24% YTD
(Reporting by Sriparna Roy)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on Butterfly Network
See all newsBrief: Bridge Neurotech And Butterfly Network Announce Partnership To Develop Fully Non-Invasive Brain-Computer Interface
Brief: Butterfly Network Appoints Mike Noonen To Board Of Directors
Butterfly Network Inc reports results for the quarter ended June 30 - Earnings Summary
Butterfly Network Q2 revenue beats on strong U.S. demand
Brief: Butterfly Network Appoints Caroll H. Neubauer To Board Of Directors